The Mount Sinai Health System is taking significant strides to enhance its cardiac facilities, addressing the uptick in demand for heart-related medical procedures. A hefty $31.2 million is being channeled into the development of a new electrophysiology lab at Mount Sinai Hospital on the Upper East Side as reported by Crain's New York. This investment aims to relocate and update its current suite, while an additional lab is expected to mitigate patient wait times by increasing current capacity.
Mount Sinai’s commitment to cardiac care is also evident in its expected 4,848 electrophysiology procedures for this year, marking a 17% increase from 2019 to 2023. In parallel, Mount Sinai South Nassau is also expanding, with a $17.7 million injection for a third cardiac catheterization lab, and a second electrophysiology lab, as this Oceanside facility anticipates a 75% soar in cardiac catheterizations by the end of 2024 compared to 2021, per details from a Hoodline report.
Beyond cardiac developments, Mount Sinai South Nassau is broadening its scope with enhanced clinical cancer trials, courtesy of a $1 million donation from The Betty Ajces Trust. This infusion of funds is designated to overcome budgeting barriers in clinical research, especially in regulatory work and staffing which are often non-reimbursable expenses. "Cancer trials require significant regulatory work and support staff, which often aren't reimbursable," Dr. Rajiv Datta, Director of Mount Sinai's Feil Cancer Center in Valley Stream, explained in an interview with Newsday. The donation is expected to enable the hospital to provide necessary support for a broader range of trials, particularly in cancers outside of breast and lung which are currently the main focus.
The expansion efforts are a direct response to the heightened volume of patient needs, considering the growing prevalence of heart disease and advancements in its management, as highlighted by the initial proposal to the state Health Department. Mount Sinai Hospital, with its over 1,100 beds is part of the eight-hospital Mount Sinai Health System, having brought in $10.8 billion in revenue last year alone. With these substantial investments in cardiac and cancer care, Mount Sinai projects a readiness to meet the rising curve of specialized healthcare demands.
